CVSI Stock Continues to Drop One Week After FDA’s CBD Hearing
CV Sciences (OTCQB:CVSI) had a leading voice in the FDA's recent hearing on CBD. Held last Friday, May 31, the hearing yielded a disappointing result because no conclusive decision regarding the benefits and safety of ... [Read]
CVSI Stock Jumps 7% After CV Sciences Announces Full Support For Assembly Bill 228
Last week, the California Assembly Appropriations Committee unanimously passed Assembly Bill 228. This week, CV Sciences, a Las Vegas-area cannabis company, announced its full support of the committee's decision; a move that seems to be ... [Read]
CVSI Stock Up 3%: What CV Sciences Has to Do to Maintain its Uptrend
Looking at the cannabis market, many are speculating CV Sciences, Inc. (OTCQB:CVSI) is on the verge of breaking out. From record revenues in its recent earnings report to distribution network expansion, it's not surprising people are ... [Read]
CV Sciences Inc. Shares Jumped Close to 10%
CV Sciences Inc. shares up nearly 10%. Shares of the Las Vegas-based medical cannabis company CV Sciences Inc. (OTC:CVSI) rose by nearly ten percent after the company released its toxicology and safety assessment of its ... [Read]